{"abstract": "Actavis is not alone in its penchant for acquisitions, Robert Cyran writes for Reuters Breakingviews. Valeant Pharmaceuticals and Endo Health Solutions are among those that have also enhanced their market values by snatching up rivals, slashing costs and minimizing taxes.", "web_url": "https://dealbook.nytimes.com/2014/02/18/actavis-deal-may-become-the-standard-for-drug-deals/", "snippet": "Actavis is not alone in its penchant for acquisitions, Robert Cyran writes for Reuters Breakingviews. Valeant Pharmaceuticals and Endo Health Solutions are among those that have also enhanced their market values by snatching up rivals, slashing co...", "lead_paragraph": "Actavis makes pharmaceutical deals look generic. Its $25 billion acquisition of Forest Laboratories follows a familiar formula in the sector. Agitating investor? Check. Low-tax jurisdiction? Check. Buyer\u2019s stock rises? Check. And with over $8 billion of value created, financiers will keep busy with their own merger success.", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/02/19/business/dbpix-breakingviews-drug/dbpix-breakingviews-drug-articleLarge.jpg", "height": 569, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2014/02/19/business/dbpix-breakingviews-drug/dbpix-breakingviews-drug-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 569}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/02/19/business/dbpix-breakingviews-drug/dbpix-breakingviews-drug-jumbo.jpg", "height": 971, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/02/19/business/dbpix-breakingviews-drug/dbpix-breakingviews-drug-superJumbo.jpg", "height": 1235, "width": 1302, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2014/02/19/business/dbpix-breakingviews-drug/dbpix-breakingviews-drug-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2014/02/19/business/dbpix-breakingviews-drug/dbpix-breakingviews-drug-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/02/19/business/dbpix-breakingviews-drug/dbpix-breakingviews-drug-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "Actavis Deal May Become the Standard for Drug Deals", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 1, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 2, "major": "N"}, {"name": "persons", "value": "Icahn, Carl C", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Actavis Group", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Endo Pharmaceuticals Holdings Inc", "rank": 5, "major": "N"}, {"name": "organizations", "value": "Forest Laboratories Inc", "rank": 6, "major": "N"}, {"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "rank": 7, "major": "N"}, {"name": "organizations", "value": "Warner Chilcott Ltd", "rank": 8, "major": "N"}, {"name": "organizations", "value": "Watson Pharmaceuticals Inc", "rank": 9, "major": "N"}], "pub_date": "2014-02-18T19:41:38+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Robert Cyran", "person": [{"firstname": "Robert", "middlename": null, "lastname": "Cyran", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/31ffba4b-9b38-5ba5-b1e4-237984ffa4eb", "word_count": 378, "uri": "nyt://article/31ffba4b-9b38-5ba5-b1e4-237984ffa4eb"}